Scientific Program

Please click here to see the whole program.

 

JUNE 25, 2019 - TUESDAY
18:00 - 19:30 Welcome Reception at Exhibition Area
Main Hall
08:30 - 08:40 Opening Ceremony
08:40 - 10:30 Session 1 - EARLY BRAIN INJURY AFTER SAH
Moderator: Javier Provencio, USA & Robert F. James, USA
08:40 - 09:00 Role of inflammation in early brain injury after SAH
Alex H. Choi,University of Texas, USA
09:00 - 09:20

Relationship between early brain injury and delayed cerebral ischemia
Loch Macdonald, Edge Therapeutics, Inc., University of Toronto USA

09:20 - 09:30 O-001 Evaluation of proinflammatory markers and corticosterone in the early phase of subarachnoid haemorrhage (SAH) using a blood injection model in male Wistar rats
Annika Bach,RWTH Aachen University, Germany
09:30 - 09:40 O-002 Cerebral energy status and altered metabolism in early brain injury after aneurysmal
SAH: First results of a prospective 31P-MRS study
(Presented by Alice Görke instead of Ondra Petr), Medical University Innsbruck, Austria
09:40 - 09:50 O-003 Role of endothelial NO-Synthase in early brain injury after experimental subarachnoid hemorrhage
Nicole Angela Terpolilli, Institute for Stroke and Dementia Research, Germany
09:50 - 10:00 O-004 TT01001 restores oxidative stress-based apoptosis via mitoNEET induced mitophagy after subarachnoid hemorrhage in rats
(Presented by Anwen Shao instead of Tongyu Zhang, The First Affiliated Hospital of Harbin Medical University, China
10:00 - 10:10 O-005 Early spontaneous spreading depolarizations deepen cerebral ischemia in an experimental
mouse SAH model
Sahin Hanalioglu, Hacettepe University, Turkey
10:10 - 10:20 O-006 Proteomic studies of cerebrospinal fluid to identify new biomarkers of early brain injury in
patients with hydrocephalus following aneurysmal subarachnoid haemorrhage
Bartosz Sokół, Poznan University of Medical Sciences, Poland
10:20 - 10:30 O-007 Delayed resolution of cerebral edema is
associated with poor outcome after non-traumatic subarachnoid hemorrhage
Verena Rass, Medical University of Innsbruck, Austria
10:30 - 11:00 Coffee Break / Posters / Exhibitors at Exhibition Area
11:00 - 12:40 Session 2 - UNRUPTURED INTRACRANIAL ANEURYSMS
Moderator: Aaron Dumont, USA & Sepideh Amin-Hanjani, USA 
11:00 - 11:20 Molecular basis for aneurysm wall formation, growth and rupture
Tomohiro Aoki, National Cerebral and Cardiovascular Center, Japan
11:20 - 11:40 Lessons learned from a 'natural history study' in
unruptured intracranial aneurysms
Akio Morita,Nippon Medical School, Japan
11:40 - 11:50 O-008 Aspirin Decreases Risk of Intracranial Aneurysm Growth in Subjects with Multiple Intracranial Aneurysms David Hasan, University of Iowa, USA
11:50 - 12:00 O-009 Management decisions on unruptured
intracranial aneurysms before and after implementation of the PHASES score
Laurie J Hollands, University Medical Center Utrecht, The Netherlands
12:00 - 12:10 O-010 Beware of the proximal aneurysm, size alone doesn’t matter: Results from the TAG database
Ammar Kadhim, The James Cook University Hospital, UK
12:10 - 12:20 O-011 Change in intracranial aneurysms morphology
during growth evaluated with MRA
Eva Leemans, University of Amsterdam, The Netherlands
12:20 - 12:30 O-012 Correlation between hemodynamics and collagen turnover measured by radiocarbon birth dating as an in vivo indicator of instability in intracranial aneurysms
Katharina Hackenberg, University Hospital Mannheim, Germany
12:30 - 12:40 O-013 A compelling economic argument to offer clipping as a treatment of choice for unruptured MCA aneurysms: results from the TAG database
Nitin Mukerji, James Cook University Hospital, UK
12:40 - 14:15 Lunch Break and Poster Session
13:00 - 13:45 Industry Sponsored Luncheon Symposium
14:15 - 15:55 Session 4 - DELAYED CEREBRAL ISCHEMIA
Moderators: Daniel Hanggi, Germany & Robert Loch Macdonald, Canada
14:15 - 14:35 20 years of research on cortical spreading depolarizations: answered and unanswered questions
Jens Dreier, Charité University Berlin,Germany
14:35 - 14:55 Is there a role for hypertension induction after the HIMALAIA trial?
Walter van den Bergh, University of Groningen, The Netherlands
14:55 - 15:05 O-020 What is the contemporary rate and outcome in patients that experience clinical deterioration due to Delayed Cerebral Ischaemia (clinical DCI) in aneurysmal Subarachnoid haemorrhage(aSAH)?
Hiren Patel, University of Manchester, UK
15:05 - 15:15 O - 021 Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk?
Marlies Wagner, Frankfurt University Hospital, Germany
15:15 - 15:25 O - 022 Outcomes in 233 patients with aneurysmal subarachnoid hemorrhage treated with a continuous intravenous low-dose heparin infusion
Robert F James, University of Louisville School of Medicine, USA
15:25 - 15:35 O - 023 Quantitative EEG-regulated and exam-controlled hemodynamic augmentation for delayed cerebral ischemia after subarachnoid hemorrhage
Julien J Cavanagh, State University of New York Downstate Medical Center, USA
15:35 - 15:45 O - 024 Altered CSF-Metabolomics after Aneurysmal SAH and Delayed Cerebral Ischemia
(Presented by Wing-Hann Ho instead of Ondra Petr), Medical University Innsbruck, Austria
15:45 - 15:55 O - 025 Predicting delayed cerebral ischemia using clinical and routine laboratory results
Bappaditya Ray, The University of Oklahoma Health Sciences Center, USA
15:55 - 16:30 Coffee Break / Posters / Exhibitors at Exhibition Area
16:30 - 18:00 Session 6 - ADVANCES/CHALLENGES IN ANEURYSM REPAIR
Moderators: Nima Etminan, Germany & Serge Marbacher, Switzerland
16:30 - 16:50 Advanced concepts for surgical repair of unruptured intracranial aneurysms
Volker Seifert, Center of Clinical Neurosciences Johann Wolfgang Goethe-University
Germany
16:50 - 17:10 Stenting of ruptured intracranial aneurysms - Pro A hybrid neurosurgeons perspective
Pasal Jabbour, Thomas Jefferson University Hospital, USA
17:10 - 17:30 Stenting of ruptured intracranial Aneurysms - Con A neurosurgical perspective
Sepideh Amin-Hanjani,University of Illinois, USA
17:30 - 17:40 O - 036 Treatment during out of office hours is not related to complications or outcome after endovascular aneurysm closure
Jasper Hans Van Lieshout, Heinrich Heine University, Germany
17:40 - 17:50 O - 037 Impact of aneursym shape and neck configuration on cerebral infarction rates related to microsurgical clipping of intracranial aneurysms.
Lukas Goertz, University of Cologne, Germany
17:50 - 18:00 O - 038 Procedural clinical complications, case-fatality risks, and risk factors in endovascular and neurosurgical treatment of unruptured intracranial aneurysms: a systematic review and meta-analysis
Annemijn Algra, University Medical Center Utrecht, The Netherlands
19:30 - 21:30 Faculty Dinner (Invitation only)

 

Parallel Hall
10:30 - 11:00 Coffee Break / Posters / Exhibitors at Exhibition Area
11:00 - 12:40 Session 3 - NEUROVASCULAR COUPLING AND CBF REGULATION AFTER SAH
Moderators: Nerissa Ko, USA & Emanuela Keller, Switzerland
11:00 - 11:20 Neurovascular coupling and CBF regulation in the healthy brain
Martin Lauritzen,  University of Copenhagen, Denmark
11:20 - 11:40 Current knowledge and future perspectives
Gerrit Alexander Schubert, RWTH Aachen University, Germany
11:40 - 11:50 O-014 Long-lasting impairment of neurovascular reactivity after experimental SAH
Nicole Angela Terpolilli, Institute for Stroke and Dementia Research, Germany
11:50 - 12:00 O-015 Impact of heme degradation products on the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage
Alexander Joerk, Jena University Hospital, Germany
12:00 - 12:10 O-016 New risk score of the early period after spontaneous subarachnoid hemorrhage: for prediction delayed cerebral ischemia
Yuanjian Fang, Zhejiang University, China
12:10 - 12:20 O-017 A Novel Method for Cerebral Blood Flow Augmentation in a Swine Model of impaired CBF: The Intracranial Pulsating Balloon
Erez Nossek, NYU 
Medical Center, USA
12:20 - 12:30 O-018 TCD and SEP together might indicate threatening of cerebral metabolic conditions in patients with subarachnoid hemorrhage and vasospasms
Alexander Erich Hartmann, Hospitals of Cologne, Germany
12:30 - 12:40 O - 019 Inhalative nitric oxide treatment for patients with severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage
Christian Fung, University of Bern, Germany
12:40 - 14:15 Lunch Break and Poster Session
14:15 - 15:55 Session 5 - Subarachnoid Hemorrhage - ORAL ABSTRACTS
Moderator: Norihito Shimamura, Japan & Jaakko Rinne, Finland
14:15 - 14:25 O - 026 Neurological Outcome before and after standardized management of patients with aneurysmal subarachnoid hemorrhage
Amr Abdulazim, University Hospital Mannheim, University of Heidelberg, Germany
14:25 - 14:35 O - 027 Is Clipping Better Than Coiling in the Treatment of Patients with Oculomotor Nerve Palsies induced by Posterior Communicating Artery Aneurysms? A Meta-analysis of Cohort Studies
Feng Zheng, First Affiliated Hospital of Gannan Medical University, China
14:35 - 14:45 O - 028 Automated Subarachnoid Hemorrhage Evaluation on Head CT Using Artificial Intelligence
Daniel Chow, University of California,USA
14:45 - 14:55 O - 029 Stereotactic Catheter Ventriculocisternostomy and Cisternal Lavage Reduces Delayed Cerebral Infarction and Improves Outcome in Patients with Poor Grade Subarachnoid Hemorrhage. A Before and After Study
Roland Roelz, Medical Center - University of Freiburg Germany
14:55 - 15:05 O - 030 Complications and outcomes following angiographically negative subarachnoid hemorrhage
Cody Lee Nesvick, Mayo Clinic, USA
15:05 - 15:15 O - 031 Renal denervation reduces cerebral vasospasm after subarachnoid hemorrhage via suppression of central sympathetic nerve activation in rats
Yushin Takemoto,Kumamoto University, Japan
15:15 - 15:25 O - 032 "Clip first policy” versus “coil first policy” for the exclusion of middle cerebral artery aneurysm
David Hassanein Berro, CHU de Caen, France
15:25 - 15:35 O - 033 The safety, feasibility, and efficacy of using continuous IV tirofiban in acute aneurysmal subarachnoid hemorrhage: preliminary results
Lauren Allan, University of Iowa Hospitals and Clinics, USA
15:35 - 15:45 O - 034 Computatinal fluid dynamics for predicting the recurrence of unruptured cerebral aneurysm after stent-assisted coil embolization
Masato Shiba, Mie University Graduate School of Medicine, Japan
15:45 - 15:55 O - 035 Elective clipping of middle cerebral artery aneurysms: clinical and radiological outcome over a period of 10 years
Tomas Menovsky, Antwerp University Hospital, Belgium
15:55 - 16:30 Coffee Break / Posters / Exhibitors at Exhibition Area
16:30 - 18:00 Session 7 - GENETIC AND BIOMARKER STUDIES
Moderator:  Ian Galea, UK & Sherry Chou, USA
16:30 - 16:50 Established and promising biomarkers in SAH
Sherry Chou, University of Pittsburgh,USA
16:50 - 17:10 The International Stroke Genetics Consortium; how it will improve our knowledge on the role of genetics in patients with intracranial aneurysms
Ynte Ruigrok, University Medical Center Utrecht, The Netherlands
17:10 - 17:20 O - 039 Haptoglobin genotype and aneurysmal subarachnoid haemorrhage: individual patient data analysis
Ben Gaastra, University Hospital Southampton NHS Foundation Trust UK
17:20 - 17:30 O - 040 Neurofilament light chain is a predictor of outcome after aneurysmal subarachnoid haemorrhage
Ian Galea,University of Southampton, UK
17:30 - 17:40 O - 041 Genetics of Intracranial aneurysm: An Indian perspective
Moinak Banerjee, Rajiv Gandhi Centre for Biotechnology, India
17:40 - 17:50 O - 042 Cell surface based multicolour flow cytometric immunophenotyping of peripheral blood T helper cell subsets after aneurysmal subarachnoid hemorrhage (SAH)
Shafqat Rasul Chaudhry, University Hospital Bonn, Pakistan
17:50 - 18:00 O - 043 Timecourse of metabolomics in CSF after aneurysmal SAH
Ondra Petr, Medical University Innsbruck, Austria
19:30 - 21:30 Faculty Dinner (Invitation only)

 

  Main Hall
08:30 - 10:10 Session 8 - UIA / SAH EPIDEMIOLOGY
Moderators: Gabriel Rinkel, The Netherlands & Jurgen Beck, Germany
08:30 - 08:50 Long-term outcomes after SAH
Gabriel Rinkel, University Medical Center Utrecht, The Netherlands
08:50 - 09:10

Risk factors for and time trends in the worldwide incidence of aneurysmal subarachnoid hemorrhage                   

Ale Algra, University Medical Center Utrecht, The Netherlands

09:10 - 09:20 O - 044 Natural history of intracranial aneurysm already treated: risk of bleeding and risk of retreatment
Thomas Metayer, CHU de Caen, France
09:20 - 09:30 O - 045 Influence and treatment of intracerebral hematoma in patients with atraumatic subarachnoid hemorrhage
Stefan Gerner, University Hospital Erlangen, Germany
09:30 - 09:40 O - 046 Comparison of rupture risk between familial and sporadic intracranial aneurysms: an individual patient data meta-analysis
Charlotte C. M. Zuurbier, University Medical Center Utrecht, The Netherlands
09:40 - 09:50 O - 047 Age Standardised Mortality and Sudden Death from Aneurysmal Subarachnoid Haemorrhage
Linda Jayne Nichols, University of Tasmania, Australia
09:50 - 10:00 O - 048 Antipsychotic drug use among 1144 patients after aneurysmal subarachnoid hemorrhage: a population-based case-control study
Juho Tapio Paavola, University of Eastern Finland,Finland
10:00 - 10:10 O - 049 Sex differences in neurological complications and outcome after aneurysmal subarachnoid haemorrhage (aSAH)
Ronil V Chandra, Monash University, Australia
10:10 - 10:45 Coffee Break / Posters / Exhibitors at Exhibition Area
10:45 - 12:30 Session 10 - ONGOING AND RECENTLY COMPLETED CLINICIAL TRIALS
Moderators: Miika Korja, Finland & Mervyn Vergouwen, The Netherlands
10:45 - 11:00 Final results of the NEWTON 2 trial
Daniel Hänggi, University of Heidelberg, Germany
11:00 - 11:15 Final results of the EARLY DRAIN trial
Stefan Wolf, Charité University Berlin, Germany
11:15 - 11:30 Aneurysmal subarachnoid hemorrhage - red blood cell transfusion and outcome (SAHaRA): a randomized controlled trial (rationale and study status)
Shane English, The Ottawa Hospital, Canada
11:30 - 11:45 ULTRA early tranexamic acid after subarachnoid hemorrhage (rationale and study status)
Peter Vandertop, Amsterdam University Medical Centers, The Netherlands
11:45 - 12:00 French Intraventricular fibrinolysis trial (rationale and study status)
Thomas Gaberel,University Hospital of Caen, France
12:00 - 12:15 PROTECT-U (rationale and study status)
Nima Etminan, Medical Faculty Mannheim, University of Heidelberg Germany
12:15 - 12:30 O - 056 Prevention of clinical deterioration due to DCI post-aneurysmal SAH (aSAH) in high-risk patients with clazosentan: The REACT study
Stephan A Mayer, Henry Ford Neuroscience Institute, USA
12:30 - 14:00 Lunch Break and Poster Session
12:30 - 14:00 12:30 - 14:00 Faculty Meeting (Studio 2)
14:00 - 15:45 Session 12 - OTHER CEREBRAL AND EXTRACEREBRAL COMPLICATIONS AFTER SAH
Moderator: Michael Diringer, USA & Carl Muroi, Switzerland
14:00 - 14:20 Subarachnoid hemorrhage is a multisystem disease
Michael Diringer,Washington University, USA
14:20 - 14:40 Respiratory complications and management in patients with SAH
Raimund Helbok, Medical University of Innsbruck, Austria

14:40 - 14:50

O - 063 Rebleeding rate in 2 comprehensive stroke units using different blood pressure management
Lionel Calviere, Toulouse Neuroimaging Center INSERM, France

14:50 - 15:00

O - 064 Prognostic Model for Chronic Shunt-Dependent Hydrocephalus following Aneurysmal Subarachnoid Haemorrhage
Hendrik-Jan Mijderwijk, Heinrich Heine University,Germany

15:00 - 15:10

O - 065 Risk Factors of Shunt Dependent Hydrocephalus in Aneurysmal Subarachnoid Hemorrhage: Our Experience and Literature Review
Maria Blagia, University of Bari, Italy
15:10 - 15.20 O - 066  Interrogating the heart-brain interaction after subarachnoid hemorrhage in the experimental and clinical setting
Ran Xu, Charité University Hospital, Germany
15:20 - 15.30 O - 067 Decompressive craniotomy for poor grade subarachnoid hemorrhage patients. Justification and Efficiency
Anton Konovalov, Burdenko Neurosurgical Institute, Russia
15:30 - 15.40 O - 068 Prognostic value of delayed cerebral edema in poor-grade SAH
Ramon Torne, Hospital Clinic of Barcelona, Spain
15:45 - 16:15 Coffee Break / Posters / Exhibitors at Exhibition Area
16:15 - 17.55 Session 14 - NOVEL IMAGING TECHNIQUES
Moderators: Thomas Gaberel, France & Jan Claassen, USA
16:15 - 16.35 Novel radiological surrogates to estimate the risk of rupture in intracranial aneurysms
David Hasan, University of Iowa Hospitals, USA
16:35 - 16.55 Quantifying MRI-specific features of injury in SAH
Sarah Nelson, Johns Hopkins Hospital, USA
16:55 - 17.05 O-079 Comparison of intra- and postoperative three-dimensional digital subtraction angiography in evaluation of the surgical result after intracranial aneurysm treatment
Serge Marbacher, Kantonsspital Aarau,Switzerland
17:05 - 17.15                           O-080 Vessel wall enhancement of IntraCranial Aneurysms on high resolution MRI:                                           a RUpture Sign? the ICARUS study
                     Fuat Arikan Abelló, Vall d’Hebron University Hospital, Spain
17:15 - 17.25 O-081 Quantitative Susceptibility Mapping (QSM) and Vessel Wall Imaging (VWI) MRI Sequences in Identifying Subjects With Intracranial Aneurysms Who Have Microbleeds
Edgar A Samaniego, University of Iowa, USA
17:25 - 17.35 O-082 Multiple Factors Contribute To Aneurysm Enhancement in Intracranial Vessel Wall Imaging: Case Series
Bart M.W. Cornelissen, University of Amsterdam, The Netherlands
17:35 - 17.45                       O-083 Slow Flow Artefacts Mimic Wall Enhancement in Magnetic Resonance Vessel Wall Imaging:                               a Phantom Study
Bart M.W. Cornelissen, University of Amsterdam, The Netherlands
17:45 - 17.55 O-084 Cinematic rendering – A novel approach for preoperative photorealistic visualization of intracranial aneurysms and vascular anatomy
Amr Abdulazim, University Hospital Mannheim, Germany
19:30 - 21:30 Networking Event
Parallel Hall
08:30 - 10:10 Session 9 - ANIMAL STUDIES
 Moderator: Nikolaus Plesnila, Germany & Tomohiro Aoki, Japan
08:30 - 08:50 Animal models in SAH research: towards standardization of experiments.
Serge Marbacher, Kantonsspital Aarau, Switzerland
08:50 - 09:10 Translation of animal research into novel clinical treatments
Nikolaus Plesnila,Ludwig- Maximilians Universitat München, Germany
09:10 - 09:20 O - 050 Meta-analysis of quality standards in in-vivo animal studies of subarachnoid haemorrhage
Davide Marco Croci, University of Bern, Switzerland
09:20 - 09:30 O - 051 Complement component 3 (C3)-mediated activation of glial and vascular microenvironment after experimental subarachnoid hemorrhage (SAH)
Aabi Okute, Charité - Universitätsmedizin, Germany
09:30 - 09:40 O - 052 A high wall shear stress and a mechanical stretch cooperatively regulate intracranial aneurysm formation
Hirokazu Koseki, Tokyo Women’s Medical University Medical Center East, Japan
09:40 - 09:50 O - 053 Neointima Formation and Thrombus Organization after Coil and Stent Treatment is Mediated by Cell Migration from the Adjacent Vital Vessel Wall in Rat Sidewall Aneurysms
Fabio Strange, Kantonsspital Aarau, Switzerland
09:50 - 10:00 O - 054 Haptoglobin attenuates parenchymal vasoconstriction and improves outcome in a mouse model of chronic intrathecal haemoglobin exposure
Patrick Garland, University of Southampton, UK
10:00 - 10:10 O - 055 The role of Na+/K+-ATPase alpha isoforms in spreading depolarization studied in knock-out mice
Clemens Reiffurth, Charité-University Medicine Berlin, Germany
10:10 - 10:45 Coffee Break / Posters / Exhibitors at Exhibition Area
10:45 - 12:30 Session 11 - NEUROINFLAMMATION
Moderators: Hidetoshi Kasuya, Japan & Alex Choi, USA
10:45 - 11:05 Defining and monitoring neuroinflammation in SAH
Nerissa Ko, University of California, USA
11:05 - 11:25 Neuroinflammation as a target for intervention in subarachnoid hemorrhage
Hidenori Suzuki, Mie University,Japan
11:25 - 11:35 O - 057 Inflammatory preconditioning against microglia-induced neuronal cell death following subarachnoid hemorrhage (SAH)
Ulf C Schneider, Charité - Universitätsmedizin Berlin, Germany
11:35 - 11:45 O - 058 Counteracting microglia (MG) development and activation to overcome inflammatory secondary brain injury after experimental subarachnoid hemorrhage(eSAH)
Ulf C Schneider, Charité - Universitätsmedizin Berlin, Germany
11:45 - 11:55 O - 059 The Interleukin-6 receptor antagonist Tocilizumab reduces vasospasms, microclot formation and neuronal cell death in a rabbit model of subarachnoid haemorrhage
Davide Marco Croci, University of Bern, Switzerland
11:55 - 12:05 O - 060 Systemic and CSF Interleukin-1alpha expression in a rabbit closed cranium subarachnoid haemorrhage model
Davide Marco Croci, University of Bern, Switzerland
12:05 - 12:15 O - 061 The natural course of cerebrospinal fluid parameters 20 days after aneurysmal subarachnoid hemorrhage
Inez Koopman, University Medical Center Utrecht, The Netherlands
12:15 - 12:25 O - 062 Clinical significance of elevated interleukin (IL)-10 levels in aneurysmal subarachnoid hemorrhage (SAH) patients
Sajjad Muhammad, University of Helsinki and Helsinki University Hospital, Finland
12:30 - 14:00 Lunch Break and Poster Session
12:30 - 14:00 Faculty Meeting (Studio 2)
14:00 - 15:45 Session 13 - ORAL ABSTRACTS
Moderators: Timo Koivisto, Finland & Hiroki Ohkuma, Japan
14:00 - 14:10 O - 069 Vitamin D – a new perspective in treatment of cerebral vasospasm
Sepide Kashefiolasl,University Hospital Frankfurt, Germany
14:10 - 14:20 O - 070 Local hemodynamics of rupture points of cerebral aneurysms evaluated with computational fluid dynamics (CFD)
Fujimaro Ishida, Mie Chuo Medical Center NHO, Japan
14:20 - 14:30 O - 071 Prediction of functional outcome using quantified blood volume in patients with aneurysmal subarachnoid hemorrhage 
Wessel Ernst Van Der Steen,University of Amsterdam, The Netherlands 
 14:30 - 14:40  O - 072  Endovascular Coiling or Neurosurgical Clipping in Aneurysmal Subarachnoid Hemorrhage? Development and Internal Validation of a Prognostic Model in the International Subarachnoid Aneurysm Trial (ISAT)
Simone A. Dijkland,Erasmus MC University Medical Center, The Netherlands
14:40 - 14.50 O - 073 Significance of tenascin-C expression in an acute phase of subarachnoid hemorrhage
Fumi Nakano, NHO Mie Chuo Medical Center, Japan
14:50 - 15.00 0 - 074 Activation of STAT3 in CA1 and the dentate gyrus after subarachnoid hemorrhage
Koji Osuka, AIchi Medical University, Japan
15:00 - 15.10 O -075 Severity of early brain injury after cerebral aneurysm rupture: a risk prediction attempt using collaborative intelligent classifiers
Nina Soultanian, Shahid Beheshti University of Medical Sciences, Iran
15:10 - 15.20 O-076 Guideline to improve poor-grade subarachnoid hemorrhage based on intraoperative pathophysiological findings
Norihito Shimamura, Hirosaki University Graduate School of Medicine, Japan
15:20 - 15.30 O-077 Systemic HMGB1, a novel predictive biomarker for cerebral vasospasm in Subarachnoid Hemorrhage
Sajjad Muhammad, University of Helsinki and Helsinki University Hospital, Finland
15:30 - 15.40 O-078 Choice of lumbar cerebrospinal fluid drainage in aneurysmal subarachnoid hemorrhage
Sheng Chen, Zhejiang University, China
15:45 - 16:15 Coffee Break / Posters / Exhibitors at Exhibition Area
16:15 - 17.55 Session 15 - NEUROPSYCHOLOGICAL AND FUNCTIONAL OUTCOMES
Moderator: Philippe Bijlenga, Switzerland &  Jorge Mejia-Mantilla, Colombia
16:15 - 16.35 Cerebral infarction and cognitive outcome after SAH
George Wong,Chinese University of Hong Kong, China
16:35 - 16.55 Neuropsychological outcomes in SAH patients: lessons learned and future perspectives
Stephan Mayer, William T. Gossett Endowed Chair of Neurology, USA
16:55 - 17.05 O-085 The ACoA syndrome revisited? Additional rebuttal by using measures for social cognition
Anne Marie Buunk, University Medical Center Groningen, The Netherlands
17:05 - 17.15 O-086 Ventricular volume in relation to cognitive outcome after aneurysmal subarachnoid hemorrhage
Irene Huenges Wajer, University Medical Center Utrecht, The Netherlands
17:15 - 17.25 O-087 Changes in neuronal activity in good grade SAH survivors correlates with neurocognitive outcomes
Leodante Da Costa, University of Toronto, Canada
17:25 - 17.35 O-088 Between-Center and Between-Country Differences in Outcome After Aneurysmal Subarachnoid Hemorrhage in the Subarachnoid Hemorrhage International Trialists (SAHIT) Repository
Simone A Dijkland, The Netherlands
17:35 - 17.45 O-089 Social cognition deficits after aneurysmal subarachnoid hemorrhage: relationship with behavioral changes and return to work
Anne Marie Buunk, University Medical Center Groningen, The Netherlands
17:45 - 17.55 O-090 Impact of autosomal dominant polycystic kidney disease on the long term outcome of aneurysmal subarachnoid hemorrhage – a matched case control study
Heidi J Nurmonen, University of Eastern Finland, Finland
19:30 - 21.30 Networking Event
Main Hall
08:30 - 10:30 Session 16 - NEUROMONITORING AND NEUROCRITICAL CARE
Moderators: Jose Suarez, USA & Alejandro Rabinstein, USA
08:30 - 08:50 Electrophysiological monitoring after aneurysmal SAH
Jan Claassen,Columbia University, USA
08:50 - 09:10 Brain monitoring after SAH: lessons learned
Javier Provencio,University of Virginia School of Medicine, USA
09:10 - 09:20 O-091 Clinical manipulation may increase cortical spreading depolarization after aneurysmal subarachnoid hemorrhage
Andrew Phillip Carlson,University of New Mexico, USA
09:20 - 09:30 O-092 Stable water-electrolyte balance by the requisite minimum supply of water and sodium yields good prognosis after aneurysmal subarachnoid hemorrhage
Eiji Shikata, Tokushima University, Japan
09:30 - 09:40 O-093 Early shunting in patients with aneurysmal subarachnoid hemorrhage: does the risk of cerebral vasospasms outweigh the risk of external ventricular drain-associated infections?
Davide Marco Croci, University of Bern, Switzerland
09:40 - 09:50 O-094 Invasive neuromonitoring to detect delayed cerebral ischemia after high-grade aneurysmal subarachnoid hemorrhage
Michael Veldeman, RWTH Aachen University, Germany
09:50 - 10:00 O-095 Decreased Odds for Repeated Vasospasm Treatment in Patients with Aneurysmal Subarachnoid Hemorrhage After Transitioning from Neurosurgery-Led Care to a Neurology-Led Multidisciplinary Approach
Stephanie L Jarvis, Swedish Medical Center: Comprehensive Stroke Center, USA
10:00 - 10:10 O-096 Impact of initial level-of-care admission in long-term clinical outcome of low-grade aneurysmal subarachnoid hemorrhage patients
Laura Llull, Hospital Clinic Barcelona, Spain
10:10 - 10:20 O-097 Induced hypertension for DCI after subarachnoid hemorrhage: Prospective quantification of treatment effect
Miriam Weiss, RWTH Aachen University, Germany
10:20 - 10:30 O-098 ICU Cockpit: Precision Medicine for the Treatment of Aneurysmal Subarachnoid Hemorrhage based on a Multimodal Neuromonitoring Database
Emanuela Keller, University Hospital Zurich, Switzerland
10:30 - 11:00 Coffee Break / Posters / Exhibitors at Exhibition Area
11:00 - 12:40 Session 18 - FUTURE PERSPECTIVES IN CLINICAL SAH RESEARCH
Moderators: Nima Etminan, Germany & Mervyn Vergouwen, The Netherlands
11:00 - 11:15 Alternative study designs for studying the effect of interventions in patients with SAH – pros and cons
Hester Lingsma, Erasmus MC,The Netherlands
11:15 - 11:30 Summary update and the future of Common Data Elements in SAH research
Jose Suarez, Johns Hopkins Hospital,USA
11:30 - 11:45 Albumin in Subarachnoid Hemorrhage (ALISAH)
Jose Suarez, Johns Hopkins Hospital,USA
11:45 - 12:00 Interleukin-1 receptor antibodies for SAH(rationale and study status)
Hiren Patel, University of Manchester, UK
12:00 - 12:10 O-107 Cerebrospinal fluid filtration in aneurysmal subarachnoid hemorrhage patients: Results from the PILLAR feasibility trial
Christa B Swisher, Duke University Medical Center,USA
12:10 - 12:20 O-108 SFX-01 after Subarachnoid haemorrhage (SAS): A phase-II multi-centre randomised double-blinded placebo-controlled trial
Ardalan Zolnourian, University Hospital Southampton, UK
12:20 - 12:30 O-109 Establishing an aneurysm database for an unusually stable cohort of patients: the (Teesside Aneurysm Group) TAG project
Dorina Roy, James Cook University Hospital UK
12:30 - 12:40 O-110 Developing a Core Outcome Set for Aneurysmal Subarachnoid Haemorrhage Research
Christopher Andersen,University of Oxford, UK
12:40 - 12:55 Future of local pharmaceutical therapies for prevention and treatment of delayed cerebral ischemia
Hidetoshi Kasuya, Tokyo Women’s Medical University Medical Center East, Japan
12:55 - 13:15 Awards and closing ceremony

 

 

Parallel Hall
08:30 - 10:30 Session 17 - Microcirculatory disturbances after SAH
Moderator: Nikolaus Plesnila, Germany & Hans-Jakob Steiger, Germany
08:30 - 08:50 Relationship between spreading depolarizations and microcirculatory disturbances after SAH
Bill Shuttleworth, University of New Mexico, USA
08:50 - 09:10 Microthrombosis and arteriolar constrictions after SAH
Hiroki Ohkuma, University of Hirosaki, Japan
09:10 - 09:20 O-099 Evaluation of the Microcirculatory Dysfunction by Arterial Spin Labeling (ASL) after Subarachnoid Hemorrhage
Masato Naraoka, University of Hirosaki, Japan
09:20 - 09:30 O-100 Ultrasound perfusion imaging for bedside detection of cerebral vasospasm after aneurysmal subarachnoid hemorrhage
Christian Fung, University of Bern, Germany
09:30 - 09:40 O-101 Automated Magnetic Resonance Perfusion Imaging in the Management of Delayed Cerebral Ischemia: A Pilot Study
Kasra Khatibi, University of California Los Angeles, USA
09:40 - 09:50 O-102 Severity and extension of transcranial doppler vasospasm relate to delayed cerebral ischemia in subarachnoid hemorrhage patients
Tommaso Zoerle, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Italy
09:50 - 10:00 O-103 Preventing cerebral vasospasm after aneurysmal subarachnoid hemorrhage with agressive cisternal clot removal and nicardipine
Nakao Ota, Sapporo Teishinkai Hospital, Japan
10:00 - 10:10 O-104 Effects of Nimodipine on blood pressure in patients with evolving vasospasms after aneurysmal subarachnoid hemorrhage
Werner J Zgraggen, University of Bern, Switzerland
10:10 - 10:20 O-105 Ultra-early and pre-interventional angiographic cerebral vasospasm after aneurysmal subarachnoid hemorrhage predicts early onset of delayed cerebral vasospasm, delayed cerebral ischemia, and poor outcome
Serge Marbacher, Kantonsspital Aarau, Switzerland
10:20 - 10:30 O-106 Characterization of cerebral blood flow (CBF) responses to KCl-induced cortical spreading depolarizations (CSD) in the acute phase of subarachnoid haemorrhage (SAH) in rats
Catharina Conzen, Uniklinik RWTH Aachen, Germany
10:30 - 11:00 Coffee Break / Posters / Exhibitors at Exhibition Area

Newsletter

Sign up to be notified of news

Venue

Muziekgebouw aan 't IJ Amsterdam
Piet Heinkade 1
1019 BR Amsterdam, The Netherlands
Founded in 2005; Muziekgebouw aan 't IJ is the most important stage for contemporary music in the Netherlands. It is located above the IJtunnel, a ten-minute walk from Amsterdam Central Station. The building was designed by Danish architects 3XN. Spacious modern rooms, parking directly under the building and an unparalleled view: Muziekgebouw aan 't IJ has it all in house.

Organization Secretariat

Kenes M+

General Inquiries:
Ms. Merve Tufekci
mtufekci@kenes.com